Position in ZTS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,288,252
+$903,495 QoQ
Shares Held
10,898
+256.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ELEVATION POINT WEALTH PARTNERS, LLC holds $6,627,844 across 9 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
141,882 | $2,627,654 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
44,201 | $1,331,334 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
10,898 | $1,288,252 | |
| 4 | VTRS |
Viatris Inc
|
39,055 | $527,633 | |
| 5 | HLN |
Haleon plc
|
40,396 | $404,363 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
3,556 | $273,456 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
12,998 | $123,740 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
10,100 | $41,915 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,288,252 | 10,898 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $384,757 | 3,058 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $598,741 | 4,092 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,020,380 | 6,543 | Shares | Sole | 2026-02-03 | |
| 2025-03-31 | $730,552 | 4,437 | Shares | Sole | 2026-02-03 | |
| 2024-12-31 | $723,572 | 4,441 | Shares | Sole | 2026-02-03 | |
| 2024-09-30 | $879,796 | 4,503 | Shares | Sole | 2026-02-03 | |
| 2024-06-30 | $756,889 | 4,366 | Shares | Sole | 2026-02-03 | |
| 2024-03-31 | $655,350 | 3,873 | Shares | Sole | 2026-02-03 | |
| 2023-12-31 | $785,137 | 3,978 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $705,314 | 4,054 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $696,245 | 4,043 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,057,226 | 6,352 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,253,002 | 8,550 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,049,744 | 7,079 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,225,231 | 7,128 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $1,426,871 | 7,566 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $2,036,918 | 8,347 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,659,702 | 8,549 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,746,379 | 9,371 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,554,642 | 9,872 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,762,740 | 10,651 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,773,427 | 10,724 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,557,459 | 11,365 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $1,531,029 | 13,009 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||